Key result
NIP-142 concentration-dependently blocked Kv1.5, Kv4.2, and Kv4.3 potassium channel currents and significantly prolonged the effective refractory period in isolated mouse atria from 43.0 ms to 71.0 ms.
Answers are grounded in this paper and cite their sources.
NIP-142 merits testing in arrhythmia models; leaves open clinical translation for atrial rhythm control.
Effects of NIP-142, a benzopyran compound which terminates experimental atrial arrhythmia, on potassium channel alpha-subunits and mouse atrial repolarization were examined. NIP-142 concentration-dependently blocked the outward current through potassium channel alpha subunits Kv1.5, Kv4.2 and Kv4.3 expressed in Xenopus oocytes. In isolated mouse atrial myocardia, NIP-142 prolonged the action potential duration and effective refractory period, and increased the contractile force. These results suggest that NIP-142 blocks the potassium channels underlying the transient and sustained outward currents, which may contribute to its antiarrhythmic activity.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2010) studied Atrial fibrillation (experimental models). NIP-142 vs. Baseline (before application) was evaluated on Potassium channel outward currents and effective refractory period (p=<0.05). NIP-142 concentration-dependently blocked Kv1.5, Kv4.2, and Kv4.3 potassium channel currents and significantly prolonged the effective refractory period in isolated mouse atria from 43.0 ms to 71.0 ms.
Synapse has enriched 10 related papers. Consider them for comparative context: